Compare Lenox Pasifik Investama Tbk. (LPPS) vs Merck Tbk. (MERK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lenox Pasifik Investama Tbk. vs Merck Tbk. — how do they compare? Lenox Pasifik Investama Tbk. trades at Rp79 (market cap 181.18B, 76.86M 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume). The key difference: Merck Tbk. is far larger — about 9.4× Lenox Pasifik Investama Tbk.'s market cap, and Lenox Pasifik Investama Tbk. is more actively traded (76.86M versus 37.6K). Which is the better fit depends on your goals.
| LPPS | MERK | |
|---|---|---|
Market Cap | 181.18B | 1.7T |
Volume | 76.86M | 37.6K |
Lot | 768.6K | 376 |
Turnover | 6.58B | 144.47M |
Average Price | 85.59 | 3,842.23 |
Value | 6.58B | 144.47M |
Indicative Equilibrium Price | 79 | 3,840 |
Indicative Equilibrium Volume | 9.22K | 7 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Lenox Pasifik Investama Tbk.
PT Lippo Securities Tbk (the Parent Company) was established on June 20, 1989 based on notarial deed No.514 of Misahardi Wilamarta, S.H. The deed of establishment was approved by the Ministry of Justice of the Republic of Indonesia (MOJ) in its decision letter No.C2-6029.HT.01.01TH.89 dated July 6, 1989, and was published in the State of Gazette No.80 Supplement No. 3904 dated October 5, 1990. Its articles of association has been amended several times, most recently by notarial deed No.113 of Ny. Poerbaningsih Asi Warsito, S.H., dated July 30,1999, concerning among others, the adjustments to effect the Regulation No.IX.D.I. On December 20, 1999, the Parent Company submitted a letter to the Chief of the Capital Market Supervisory Board requesting for the revocation of its business license as broker, in connection with the merger of its brokering activities with PT Ciptadana Sekuritas, a subsidiary. This request was approved by the Chief of the Capital Market Supervisory Board based on its decision letter No. 01/PM/2000 dated January 5, 2000.In view of the foregoing, PT Bursa Efek Jakarta in its letter No.S.024/BEJ.ANG/01-2000 dated January 12, 2000 and PT Bursa Efek Surabaya in its letter No. T1-003/AGT/BES/I/2000 dated January 1, 2000, cancelled their Approval Letter on Stock Exchange Membership (Surat Persetujuan Anggota Bursa) issued to the Parent Company effective January 13, 2000 and January 4, 2000, respectively. Accordingly, the Parent Company is required to sell its investments in shares of stock of PT Bursa Efek Jakarta and PT Bursa Efek Surabaya.
Read more on LPPS →About Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →
